Referenceprogram for behandling af knæartrose - Sundhedsstyrelsen

128) Jackson, R. W. & Dieterichs, C. 2003, "The results of arthroscopic lavage
and debridement of osteoarthritic knees based on the severity of degeneration:
a 4- to 6-year symptomatic follow-up", Arthroscopy : The Journal of Arthroscopic
& Related Surgery : Official Publication of the Arthroscopy Association
of North America and the International Arthroscopy Association, vol. 19, no.
1, pp. 13-20.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&d
opt=Citation&list_uids=12522398
129) Jahromi, I., Walton, N. P., Dobson, P. J., Lewis, P. L., & Campbell, D. G.
2004, "Patient-perceived outcome measures following unicompartmental knee
arthroplasty with mini-incision", International orthopaedics, vol. 28, no. 5, pp.
286-289.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&d
opt=AbstractPlus&list_uids=15480659&query_hl=31&itool=pubmed_docsum
130) Jensen, H., Harreby, M., & Kjer, J. 1987, "[Infrared laser--effect in painful
arthrosis of the knee?]", Ugeskrift for laeger, vol. 149, no. 46, pp. 3104-3106.
131) Johnsen, S. P., Larsson, H., Tarone, R. E., McLaughlin, J. K., Norgard, B.,
Friis, S., & Sorensen, H. T. 2005, "Risk of hospitalization for myocardial infarction
among users of rofecoxib, celecoxib, and other NSAIDs: a populationbased
case-control study", Archives of Internal Medicine, vol. 165, no. 9, pp.
978-984.
132) Johnson, A. G. 1997, "NSAIDs and increased blood pressure. What is the
clinical significance?", Drug Saf, vol. 17, no. 5, pp. 277-289.
133) Jones, C. A., Voaklander, D. C., & Suarez Almazor, M. E. 2003, "Determinants
of function after total knee arthroplasty", Physical therapy, vol. 83, no. 8,
pp. 696-706.
134) Jones, J. & Hunter, D. 1995, "Consensus methods for medical and health services
research", BMJ, vol. 311, no. 7001, pp. 376-380.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&d
opt=Citation&list_uids=7640549
135) Jordan, K. M., Arden, N. K., Doherty, M., Bannwarth, B., Bijlsma, J. W.,
Dieppe, P., Gunther, K., Hauselmann, H., Herrero-Beaumont, G., Kaklamanis,
P., Lohmander, S., Leeb, B., Lequesne, M., Mazieres, B., Martin-Mola, E.,
Pavelka, K., Pendleton, A., Punzi, L., Serni, U., Swoboda, B., Verbruggen, G.,
Zimmerman-Gorska, I., & Dougados, M. 2003, "EULAR Recommendations
2003: an evidence based approach to the management of knee osteoarthritis:
Report of a Task Force of the Standing Committee for International Clinical
Studies Including Therapeutic Trials (ESCISIT)", Annals of the Rheumatic
Diseases, vol. 62, no. 12, pp. 1145-1155.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&d
opt=Citation&list_uids=14644851
136) Juni, P., Reichenbach, S., & Egger, M. 2005, "COX 2 inhibitors, traditional
NSAIDs, and the heart", BMJ, vol. 330, no. 7504, pp. 1342-1343.
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&d
opt=Citation&list_uids=15947376
Referenceprogram for behandling af knæartrose – september 2007 88